ReviewCardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managing
Under a Creative Commons license
open access
Keywords
Tyrosine kinase inhibitor
Chronic myeloid leukemia
Cardiovascular toxicity
Pulmonary toxicity
Metabolic toxicity
Cited by (0)
© 2018 The Authors. Published by Elsevier Ltd.